Nuechterlein Carole

Aligos Therapeutics, Inc. · Director

Nuechterlein Carole is listed in public filings as director. This Nuechterlein Carole insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aligos Therapeutics, Inc. (ALGS). Investors use Nuechterlein Carole's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Aligos Therapeutics, Inc.ALGS$45k5.9k sharesGrant / ExerciseJun 25, 2025$44.7K5.9k shares$7.63--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Aligos Therapeutics, Inc.ALGS$23k60k sharesGrant / ExerciseJun 27, 2024$22.8K60k shares$0.38--